MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS

• Main Authors: CARSTEN MOELLER, OLIVER-MARTIN FISCHER, ANJA SCHMIDT, ULRIKE KAUFMANN-REICHE, ULRIKE FUHRMANN
• Format: Patent
• Language: English; Spanish
• Published: 11.09.2009
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The aim of the present invention is the use of mineralcorticoid receptor antagonists for the production of a drug for the treatment of endometriosis. The present invention particularly relates to an improved therapeutic agent against endometriosis, which has a more favorable effectiveness profile and/or profile of side effects than previously available treatment therapies. With a mineralcorticoid receptor antagonist, endometriosis can be lastingly treated without resulting in a loss of bone mass. Es objeto de la presente invención el uso de antagonistas del receptor de mineralocorticoides para preparar un medicamento para el tratamiento de endometriosis. En especial, la presente invención se refiere a un agente terapéutico mejorado contra la endometriosis, que muestra un perfil de acción o de efectos colaterales más ventajoso que las terapias de tratamiento disponibles hasta ahora. Con un antagonista del receptor de mineralocorticoides se puede tratar la endometriosis de modo duradero, sin que se produzca, en este caso, una pérdida de la masa ósea.